Valeo Financial Advisors LLC lowered its position in GSK plc (NYSE:GSK – Free Report) by 31.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and ...

The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in 2024 and an ...

The North East Pharma, Health Tech, and Life Sciences Landscape Survey 2024 has revealed rising business confidence for 2025 among North East ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

The other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the ...

Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...

Indian markets closed nearly flat as IT gains offset consumer stock declines. Persistent FII outflows, weak earnings, and global trade worries kept sentiment cautious, while small and midcap stocks ...

Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...

Mike Stella, CEO of Ascend Advanced Therapies, joins the Board at GeminiBio to provide strategic leadership in the fields of ...

The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel ...

Valeo Financial Advisors LLC grew its stake in shares of Bank of Montreal (NYSE:BMO – Free Report) (TSE:BMO) by 4.6% during ...